Fundraising FoxConjupro Biotherapeutics
Princeton, US · Delaware corporation
Find your way into Conjupro Biotherapeutics
Sign up to see every warm intro you have to Conjupro Biotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Conjupro Biotherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Conjupro Biotherapeutics is a biopharmaceutical company conducting clinical research and drug development for oncology, cardiology, and CNS diseases. Founded in 2017 as a subsidiary of CSPC Pharmaceutical Company Ltd., it is based in Princeton, NJ.
Founders & leadership
HW
Haixing WangNamed on SEC filing
QW
Qingxi WangNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$9.3M disclosed across 1 round · 2023
▶$9.3MraisedSep 2023 · 1 investors · OtherRule 506(b)
▶$9.3MraisedSep 2023 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Haixing WangExecutive Officer
- Qingxi WangExecutive Officer, Director
- Offering amount
- $67.5M
- Amount sold
- $9.3M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
GlobaldataGlobalData provides an AI-powered intelligence platform that delivers research, market analysis, and predictive insights to enterprises across industries. The platform combines proprietary data, in-house subject matter experts, and AI tools to support critical business decisions.
BaiduChina's leading search engine and AI technology company
PerplexityAn AI-powered answer engine providing accurate, trusted, and real-time answers to questions.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies working in the same space as Conjupro Biotherapeutics.
In the news
Frequently asked questions
- What does Conjupro Biotherapeutics do?
- Conjupro Biotherapeutics is a biopharmaceutical company conducting clinical research and drug development for oncology, cardiology, and CNS diseases. Founded in 2017 as a subsidiary of CSPC Pharmaceutical Company Ltd., it is based in Princeton, NJ.
- How much funding has Conjupro Biotherapeutics raised?
- Conjupro Biotherapeutics has disclosed $9.3M raised across 1 round.
- Where is Conjupro Biotherapeutics headquartered?
- Conjupro Biotherapeutics is headquartered in Princeton, US.